Vanguard Trims Hologic Stake to 7.8% as of Dec 29, 2023
Ticker: HOLX · Form: SC 13G/A · Filed: Feb 13, 2024 · CIK: 859737
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**Vanguard cut its Hologic stake to 7.8%, watch for market reaction.**
AI Summary
The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in Hologic Inc. As of December 29, 2023, Vanguard beneficially owned 19,007,850 shares of Hologic's Common Stock, representing 7.8% of the company. This filing indicates a slight decrease from their previous reported ownership, which matters to investors as large institutional holdings can influence stock stability and market perception.
Why It Matters
Large institutional ownership changes can signal shifts in confidence or portfolio rebalancing, potentially impacting Hologic's stock price and investor sentiment.
Risk Assessment
Risk Level: low — A minor adjustment by a large institutional investor like Vanguard typically doesn't pose a significant immediate risk to the company.
Analyst Insight
Investors should monitor Hologic Inc.'s stock performance and other institutional filings to see if this minor reduction by Vanguard is part of a broader trend or an isolated portfolio adjustment.
Key Numbers
- 19,007,850 — Shares Beneficially Owned (The total number of Hologic Inc. Common Stock shares owned by The Vanguard Group as of December 29, 2023.)
- 7.8% — Percentage of Class (The percentage of Hologic Inc.'s Common Stock owned by The Vanguard Group, indicating their significant but slightly reduced stake.)
- December 29, 2023 — Event Date (The specific date that triggered the requirement for The Vanguard Group to file this amendment, providing a clear snapshot of their holdings.)
Key Players & Entities
- The Vanguard Group (company) — reporting person and institutional investor
- Hologic Inc (company) — subject company whose securities are being reported
- 19,007,850 shares (dollar_amount) — total shares beneficially owned by Vanguard
- 7.8% (dollar_amount) — percentage of Hologic's class of securities owned by Vanguard
- December 29, 2023 (date) — date of event requiring the filing
Forward-Looking Statements
- Hologic Inc. stock may experience minor price volatility due to the reported decrease in Vanguard's stake. (Hologic Inc.) — medium confidence, target: within 1 week
FAQ
Who is the reporting person in this SC 13G/A filing?
The reporting person is The Vanguard Group, identified with IRS Identification No. 23-1945930 and organized in Pennsylvania.
What is the subject company whose securities are being reported?
The subject company is Hologic Inc., with CUSIP Number 436440101, a company in the X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS industry.
How many shares of Hologic Inc. Common Stock does The Vanguard Group beneficially own as of the event date?
As of December 29, 2023, The Vanguard Group beneficially owns 19,007,850 shares of Hologic Inc. Common Stock.
What percentage of Hologic Inc.'s Common Stock does The Vanguard Group own?
The Vanguard Group owns 7.8% of Hologic Inc.'s Common Stock, as stated in the filing.
What was the date of the event that required this Schedule 13G/A filing?
The date of the event which required the filing of this statement was December 29, 2023.
Filing Stats: 806 words · 3 min read · ~3 pages · Grade level 11.4 · Accepted 2024-02-13 17:06:16
Filing Documents
- tv01126-hologicinc.htm (SC 13G/A) — 11KB
- 0001104659-24-021128.txt ( ) — 13KB
(a) - Name of Issuer
Item 1(a) - Name of Issuer: Hologic Inc
(b) - Address of Issuer's Principal Executive Offices
Item 1(b) - Address of Issuer's Principal Executive Offices: 250 Campus Drive Marlborough, MA 01752
(a) - Name of Person Filing
Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930
(b) – Address of Principal Business Office or, if none, residence
Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355
(c) – Citizenship
Item 2(c) – Citizenship: Pennsylvania
(d) - Title of Class of Securities
Item 2(d) - Title of Class of Securities: Common Stock
(e) - CUSIP Number
Item 2(e) - CUSIP Number 436440101
- Type of Filing
Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E).
- Ownership
Item 4 - Ownership: (a) Amount Beneficially Owned: (b) Percent of Class: (c) Number of shares as to which such person has: (i) sole power to vote or direct to vote: (ii) shared power to vote or direct to vote: (iii) sole power to dispose of or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Comments: The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.
- Ownership of Five Percent or Less of a Class
Item 5 - Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following
- Ownership of More Than Five Percent on Behalf of Another Person
Item 6 - Ownership of More Than Five Percent on Behalf of Another Person: The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%. Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company: Not applicable
- Identification and Classification of Members of Group
Item 8 - Identification and Classification of Members of Group: Not applicable
- Notice of Dissolution of Group
Item 9 - Notice of Dissolution of Group: Not applicable
- Certification
Item 10 - Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2024 By /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration